BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27824051)

  • 41. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
    Pine SR; Wiemels JL; Jayabose S; Sandoval C
    Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia.
    Zhao L; Zhang P; Galbo PM; Zhou X; Aryal S; Qiu S; Zhang H; Zhou Y; Li C; Zheng D; Bhatia R; Lu R
    Blood Adv; 2021 Nov; 5(22):4727-4740. PubMed ID: 34597364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease.
    Forgione MO; McClure BJ; Eadie LN; Yeung DT; White DL
    Cancer Lett; 2020 Jan; 469():410-418. PubMed ID: 31705930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.
    Garrido Castro P; van Roon EHJ; Pinhanços SS; Trentin L; Schneider P; Kerstjens M; Te Kronnie G; Heidenreich O; Pieters R; Stam RW
    Leukemia; 2018 Feb; 32(2):323-331. PubMed ID: 28690313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.
    Russell LJ; Jones L; Enshaei A; Tonin S; Ryan SL; Eswaran J; Nakjang S; Papaemmanuil E; Tubio JM; Fielding AK; Vora A; Campbell PJ; Moorman AV; Harrison CJ
    Genes Chromosomes Cancer; 2017 May; 56(5):363-372. PubMed ID: 28033648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
    Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
    Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
    Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
    Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two novel fusion genes, AIF1L-ETV6 and ABL1-AIF1L, result together with ETV6-ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin.
    Lukes J; Potuckova E; Sramkova L; Stary J; Starkova J; Trka J; Votava F; Zuna J; Zaliova M
    Genes Chromosomes Cancer; 2018 Sep; 57(9):471-477. PubMed ID: 29726059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
    Nasedkina TV; Ikonnikova AY; Tsaur GA; Karateeva AV; Ammour YI; Avdonina MA; Karachunskii AI; Zasedatelev AS
    Mol Biol (Mosk); 2016; 50(6):968-977. PubMed ID: 28064313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.
    Oliveira T; Zhang M; Joo EJ; Abdel-Azim H; Chen CW; Yang L; Chou CH; Qin X; Chen J; Alagesan K; Almeida A; Jacob F; Packer NH; von Itzstein M; Heisterkamp N; Kolarich D
    Theranostics; 2021; 11(19):9519-9537. PubMed ID: 34646384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features and outcomes of fusion gene defined adult Ph-negative B-cell precursor acute lymphoblastic leukemia patients: A single institutional report.
    Sun K; Wang J; Chen WM; Xu N; Long LY; Wang X; Jiang H; Jiang Q; Huang XJ; Qin YZ
    Biomol Biomed; 2023 Mar; 23(2):298-309. PubMed ID: 36124444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.
    Juszczynski P; Rodig SJ; Ouyang J; O'Donnell E; Takeyama K; Mlynarski W; Mycko K; Szczepanski T; Gaworczyk A; Krivtsov A; Faber J; Sinha AU; Rabinovich GA; Armstrong SA; Kutok JL; Shipp MA
    Clin Cancer Res; 2010 Apr; 16(7):2122-30. PubMed ID: 20332322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.
    Hjalgrim LL; Madsen HO; Melbye M; Jørgensen P; Christiansen M; Andersen MT; Pallisgaard N; Hokland P; Clausen N; Ryder LP; Schmiegelow K; Hjalgrim H
    Br J Cancer; 2002 Oct; 87(9):994-9. PubMed ID: 12434291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia.
    Brown LM; Lonsdale A; Zhu A; Davidson NM; Schmidt B; Hawkins A; Wallach E; Martin M; Mechinaud FM; Khaw SL; Bartolo RC; Ludlow LEA; Challis J; Brooks I; Petrovic V; Venn NC; Sutton R; Majewski IJ; Oshlack A; Ekert PG
    Blood Adv; 2020 Mar; 4(5):930-942. PubMed ID: 32150610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
    Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation.
    Orlovsky K; Kalinkovich A; Rozovskaia T; Shezen E; Itkin T; Alder H; Ozer HG; Carramusa L; Avigdor A; Volinia S; Buchberg A; Mazo A; Kollet O; Largman C; Croce CM; Nakamura T; Lapidot T; Canaani E
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7956-61. PubMed ID: 21518888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.
    Vega-García N; Malatesta R; Estella C; Pérez-Jaume S; Esperanza-Cebollada E; Torrebadell M; Català A; Gassiot S; Berrueco R; Ruiz-Llobet A; Alonso-Saladrigues A; Mesegué M; Pont-Martí S; Rives S; Camós M
    Br J Haematol; 2018 Aug; 182(4):542-553. PubMed ID: 29978456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.
    Li J; Dai Y; Wu L; Zhang M; Ouyang W; Huang J; Chen S
    Front Med; 2021 Jun; 15(3):347-371. PubMed ID: 33400146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.
    Hoffmann J; Krumbholz M; Gutiérrez HP; Fillies M; Szymansky A; Bleckmann K; Zur Stadt U; Köhler R; Kuiper RP; Horstmann M; von Stackelberg A; Eckert C; Metzler M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27780. PubMed ID: 31034759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.